Synopsis of recent research by authors named "Weiyi Fang"
- Weiyi Fang's recent research explores the mechanistic pathways in various diseases, including the role of the GPR30 agonist in mitigating sepsis-induced cardiac dysfunction and the activation of SIX4 in colorectal cancer by enhancing inflammatory signaling.
- His work on microRNA-2110 in nasopharyngeal carcinoma highlights its potential as a metastatic suppressor and the involvement of MYH9 in tumor progression and cellular responses in glioma and other cancers.
- Fang's studies also encompass advancements in clinical outcomes for elderly ST-elevation myocardial infarction patients through innovative reperfusion strategies and insights into cancer immunotherapy biomarkers, emphasizing the potential for personalized treatment approaches.
